Company intelligence / Profile preview
Langzhi Group Shuangren Pharmaceutical
- Ownership
- Private
- Employees
- ~2000
- Development stage
- Other
Overview
Langzhi Group Shuangren Pharmaceutical is a Chinese pharmaceutical enterprise that integrates the research, development, and production of chemical drugs and Traditional Chinese Medicine (TCM). Based in Shanxi Province, the company serves as a key manufacturing and commercial arm of the Langzhi Group, focusing on high-demand therapeutic areas including cardiovascular, cerebrovascular, and respiratory health. Its product portfolio features a mix of modern chemical formulations, such as widely used cold and flu treatments, alongside standardized TCM products. The company operates large-scale GMP-certified facilities and is recognized for its "Shuangren" brand, which maintains a significant presence in both the Chinese domestic retail and hospital markets. Langzhi Group emphasizes a "dual-wheel" strategy, combining modern pharmacological innovation with traditional herbal expertise to address chronic and acute conditions.
- Therapeutic areas
- CardiovascularInfectious Diseases
- Modalities
- Small moleculeTraditional Chinese Medicine
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Langzhi Group Shuangren Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Langzhi Group Shuangren Pharmaceutical.